TC
SANA icon

Truvestments Capital’s Sana Biotechnology SANA Stock Holding History

Truvestments Capital’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$864 Buy
+300
New +$1.18K ﹤0.01% 1066
2024
Q4 		– Sell
-50
Closed -$208 – 1052
2024
Q3 		$208 Buy
+50
New +$263 ﹤0.01% 901

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Truvestments Capital's SANA Position: Q1 2026 in Review

Truvestments Capital opened a new position in Sana Biotechnology (SANA) in Q1 2026: 300 shares worth $864. The stake represents ﹤0.01% of the portfolio and ranks #1066 among its holdings. This is a return to the name: Truvestments Capital previously reported a position in SANA as recently as Q3 2024.

Truvestments Capital first reported a position in SANA in Q3 2024 and has held it in 2 quarters since. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Truvestments Capital held 300 shares of Sana Biotechnology worth $864 as of Q1 2026.
  • Sana Biotechnology was a new Truvestments Capital position in Q1 2026.
  • Sana Biotechnology made up ﹤0.01% of Truvestments Capital's portfolio in Q1 2026, its #1066 holding.
  • Truvestments Capital first reported a position in Sana Biotechnology in Q3 2024 and has held it in 2 quarters since.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.